Coluracetam vs Huperzine A

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

ColuracetamHuperzine A
CategoryNootropicsNootropics
Standard Dose20-80 mg/day divided into 2-3 doses50-200 mcg twice daily
TimingMorning and early afternoon. Sublingual administration may provide faster onset. With or without food.Morning and early afternoon. With or without food.
Cycle DurationCycles of 4-8 weeks on, 2-4 weeks offCycle 2-4 weeks on, 1-2 weeks off to prevent AChE downregulation
Evidence Levelanimal_plus_anecdotalstrong_human
A

Coluracetam

Nootropics

Mechanism

Enhances high-affinity choline uptake (HACU) via a unique mechanism distinct from other racetams — it increases HACU even in damaged cholinergic neurons, suggesting a choline uptake enhancement rather than mere stimulation. This HACU enhancement persists even after the compound has been cleared, indicating a lasting modification of choline transporter activity. Also shows affinity for AMPA receptors.

Standard Dosing

20-80 mg/day divided into 2-3 doses

Timing

Morning and early afternoon. Sublingual administration may provide faster onset. With or without food.

Cycle Duration

Cycles of 4-8 weeks on, 2-4 weeks off

Side Effects

  • Headache
  • Fatigue at high doses
  • Brain fog (paradoxical, at excessive doses)
  • Irritability

Contraindications

  • Known hypersensitivity to racetams
  • Bipolar disorder (anecdotal reports of mood instability)

Best Stacking Partners

Alpha-GPCCDP-CholineAniracetamUridine
B

Huperzine A

Nootropics

Mechanism

Potent, selective, and reversible inhibitor of acetylcholinesterase (AChE), derived from the club moss Huperzia serrata. Exhibits preference for the tetrameric G4 form of AChE predominant in the mammalian brain. Eight-fold more potent than donepezil and two-fold more potent than rivastigmine at AChE inhibition. Crosses the BBB efficiently. Also antagonizes NMDA receptors at high concentrations and provides neuroprotection via attenuation of oxidative stress, regulation of apoptotic proteins (Bcl-2, Bax, P53, caspase-3), and upregulation of NGF.

Standard Dosing

50-200 mcg twice daily

Timing

Morning and early afternoon. With or without food.

Cycle Duration

Cycle 2-4 weeks on, 1-2 weeks off to prevent AChE downregulation

Side Effects

  • Nausea
  • Diarrhea
  • Sweating
  • Blurred vision
  • Muscle twitching
  • Bradycardia at high doses

Contraindications

  • Bradycardia
  • Asthma/COPD (cholinergic bronchoconstriction)
  • GI obstruction
  • Concurrent use of prescription AChE inhibitors
  • Peptic ulcer disease

Best Stacking Partners

Alpha-GPCLion's ManeBacopa Monnieri

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →